DDrare: Database of Drug Development for Rare Diseases

告示番号	疾患名（ページ内リンク）	臨床試験数
97	潰瘍性大腸炎	1

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03038711 (ClinicalTrials.gov)	February 1, 2017	26/1/2017	A Multiple Dose Study to Assess the Safety and Tolerability of BMS-986166 in Healthy Volunteers	A Randomized, Double Blind, Placebo-Controlled, Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of BMS-986166 in Healthy Subjects	Ulcerative Colitis	Drug: BMS-986166;Other: Placebo matching BMS-986166	Bristol-Myers Squibb	NULL	Completed	18 Years	55 Years	All	213	Phase 1	United States

No.

TrialID

Date_
enrollment

Date_
registration

Public_title

Scientific_title

Condition

Intervention

Primary_
sponsor

Secondary_
sponsor

Recruitment_
Status

Inclusion_
agemin

Inclusion_
agemax

Inclusion_
gender

Target_
size

Phase

Countries

NCT03038711
(ClinicalTrials.gov)

February 1, 2017

26/1/2017

A Multiple Dose Study to Assess the Safety and Tolerability of BMS-986166 in Healthy Volunteers

A Randomized, Double Blind, Placebo-Controlled, Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of BMS-986166 in Healthy Subjects

Ulcerative Colitis

Drug: BMS-986166;Other: Placebo matching BMS-986166

Bristol-Myers Squibb

NULL

Completed

18 Years

55 Years

All

213

Phase 1

United States